$BPMC Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Blueprint Medicines Corp.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Blueprint Medicines Corp. Get notifications about new insider transactions in Blueprint Medicines Corp for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 14 2021 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Option Exercise | M | 1.87 | 7,500 | 14,025 | 166,403 | |
| May 14 2021 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Option Exercise | M | 15.01 | 17,500 | 262,675 | 122,500 | |
| May 14 2021 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 91.89 | 2,953 | 271,351 | 172,448 | 175.4 K to 172.4 K (-1.68 %) |
| May 14 2021 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 92.62 | 16,383 | 1,517,393 | 175,401 | 191.8 K to 175.4 K (-8.54 %) |
| May 14 2021 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 93.33 | 5,664 | 528,621 | 191,784 | 197.4 K to 191.8 K (-2.87 %) |
| May 14 2021 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Buy | M | 15.01 | 17,500 | 262,675 | 197,448 | 179.9 K to 197.4 K (+9.73 %) |
| May 14 2021 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Buy | M | 1.87 | 7,500 | 14,025 | 179,948 | 172.4 K to 179.9 K (+4.35 %) |
| Mar 17 2021 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Option Exercise | M | 36.05 | 1,000 | 36,050 | 3,591 | |
| Mar 17 2021 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Sell | S | 104.65 | 322 | 33,697 | 53,948 | 54.3 K to 53.9 K (-0.59 %) |
| Mar 17 2021 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Sell | S | 105.44 | 426 | 44,917 | 54,270 | 54.7 K to 54.3 K (-0.78 %) |
| Mar 17 2021 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Sell | S | 106.62 | 108 | 11,515 | 54,696 | 54.8 K to 54.7 K (-0.20 %) |
| Mar 17 2021 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Sell | S | 107.42 | 138 | 14,824 | 54,804 | 54.9 K to 54.8 K (-0.25 %) |
| Mar 17 2021 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Sell | S | 108.16 | 6 | 649 | 54,942 | 54.9 K to 54.9 K (-0.01 %) |
| Mar 17 2021 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Buy | M | 36.05 | 1,000 | 36,050 | 54,948 | 53.9 K to 54.9 K (+1.85 %) |
| Mar 17 2021 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Option Exercise | M | 36.05 | 1,000 | 36,050 | 3,591 | |
| Mar 17 2021 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Sell | S | 104.65 | 322 | 33,697 | 53,948 | 54.3 K to 53.9 K (-0.59 %) |
| Mar 17 2021 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Sell | S | 105.44 | 426 | 44,917 | 54,270 | 54.7 K to 54.3 K (-0.78 %) |
| Mar 17 2021 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Sell | S | 106.62 | 108 | 11,515 | 54,696 | 54.8 K to 54.7 K (-0.20 %) |
| Mar 17 2021 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Sell | S | 107.42 | 138 | 14,824 | 54,804 | 54.9 K to 54.8 K (-0.25 %) |
| Mar 17 2021 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Sell | S | 108.16 | 6 | 649 | 54,942 | 54.9 K to 54.9 K (-0.01 %) |
| Mar 17 2021 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Buy | M | 36.05 | 1,000 | 36,050 | 54,948 | 53.9 K to 54.9 K (+1.85 %) |
| Mar 05 2021 | BPMC | Blueprint Medicine ... | Durso-Bumpus Debra | Chief People Office ... | Sell | S | 86.61 | 1,584 | 137,190 | 30,874 | 32.5 K to 30.9 K (-4.88 %) |
| Mar 05 2021 | BPMC | Blueprint Medicine ... | Durso-Bumpus Debra | Chief People Office ... | Sell | S | 88.96 | 109 | 9,697 | 32,458 | 32.6 K to 32.5 K (-0.33 %) |
| Mar 05 2021 | BPMC | Blueprint Medicine ... | Hurley Ariel | Principal Accountin ... | Sell | S | 86.61 | 804 | 69,634 | 11,799 | 12.6 K to 11.8 K (-6.38 %) |
| Mar 05 2021 | BPMC | Blueprint Medicine ... | Hurley Ariel | Principal Accountin ... | Sell | S | 89.24 | 53 | 4,730 | 12,603 | 12.7 K to 12.6 K (-0.42 %) |
| Mar 05 2021 | BPMC | Blueprint Medicine ... | Hurley Ariel | Principal Accountin ... | Sell | S | 98.45 | 515 | 50,702 | 12,656 | 13.2 K to 12.7 K (-3.91 %) |
| Mar 05 2021 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Sell | S | 86.61 | 1,828 | 158,323 | 53,948 | 55.8 K to 53.9 K (-3.28 %) |
| Mar 05 2021 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Sell | S | 89.09 | 124 | 11,047 | 55,776 | 55.9 K to 55.8 K (-0.22 %) |
| Mar 05 2021 | BPMC | Blueprint Medicine ... | Landsittel Michael | Chief Financial Off ... | Sell | S | 86.61 | 1,411 | 122,207 | 28,905 | 30.3 K to 28.9 K (-4.65 %) |
| Mar 05 2021 | BPMC | Blueprint Medicine ... | Landsittel Michael | Chief Financial Off ... | Sell | S | 88.98 | 96 | 8,542 | 30,316 | 30.4 K to 30.3 K (-0.32 %) |
| Mar 05 2021 | BPMC | Blueprint Medicine ... | McCain Tracey L | EVP and Chief Legal ... | Sell | S | 86.61 | 1,772 | 153,473 | 32,852 | 34.6 K to 32.9 K (-5.12 %) |
| Mar 05 2021 | BPMC | Blueprint Medicine ... | McCain Tracey L | EVP and Chief Legal ... | Sell | S | 89.00 | 121 | 10,769 | 34,624 | 34.7 K to 34.6 K (-0.35 %) |
| Mar 05 2021 | BPMC | Blueprint Medicine ... | Murray Christopher K. | SVP, Technical Oper ... | Sell | S | 86.61 | 1,133 | 98,129 | 18,888 | 20 K to 18.9 K (-5.66 %) |
| Mar 05 2021 | BPMC | Blueprint Medicine ... | Murray Christopher K. | SVP, Technical Oper ... | Sell | S | 89.02 | 77 | 6,855 | 20,021 | 20.1 K to 20 K (-0.38 %) |
| Mar 05 2021 | BPMC | Blueprint Medicine ... | Rossi Christina | Chief Commercial Of ... | Sell | S | 86.61 | 1,272 | 110,168 | 31,723 | 33 K to 31.7 K (-3.86 %) |
| Mar 05 2021 | BPMC | Blueprint Medicine ... | Rossi Christina | Chief Commercial Of ... | Sell | S | 89.10 | 87 | 7,752 | 32,995 | 33.1 K to 33 K (-0.26 %) |
| Mar 05 2021 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Option Exercise | M | 8.80 | 10,000 | 88,000 | 7,170 | |
| Mar 05 2021 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 86.61 | 8,417 | 728,996 | 172,448 | 180.9 K to 172.4 K (-4.65 %) |
| Mar 05 2021 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 88.63 | 569 | 50,430 | 180,865 | 181.4 K to 180.9 K (-0.31 %) |
| Mar 05 2021 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 86.61 | 100 | 8,661 | 181,434 | 181.5 K to 181.4 K (-0.06 %) |
| Mar 05 2021 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 89.18 | 100 | 8,918 | 181,534 | 181.6 K to 181.5 K (-0.06 %) |
| Mar 05 2021 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 90.18 | 404 | 36,433 | 181,634 | 182 K to 181.6 K (-0.22 %) |
| Mar 05 2021 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 90.99 | 3,000 | 272,970 | 182,038 | 185 K to 182 K (-1.62 %) |
| Mar 05 2021 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 91.78 | 5,296 | 486,067 | 185,038 | 190.3 K to 185 K (-2.78 %) |
| Mar 05 2021 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 93.21 | 1,100 | 102,531 | 190,334 | 191.4 K to 190.3 K (-0.57 %) |
| Mar 05 2021 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Buy | M | 8.80 | 10,000 | 88,000 | 191,434 | 181.4 K to 191.4 K (+5.51 %) |
| Mar 03 2021 | BPMC | Blueprint Medicine ... | Rossi Christina | Chief Commercial Of ... | Option Exercise | A | 100.13 | 26,125 | 2,615,896 | 26,125 | |
| Mar 03 2021 | BPMC | Blueprint Medicine ... | Rossi Christina | Chief Commercial Of ... | Grant | A | 0.00 | 13,062 | 0 | 33,082 | 20 K to 33.1 K (+65.24 %) |
| Mar 03 2021 | BPMC | Blueprint Medicine ... | Durso-Bumpus Debra | Chief People Office ... | Option Exercise | A | 100.13 | 26,125 | 2,615,896 | 26,125 | |
| Mar 03 2021 | BPMC | Blueprint Medicine ... | Durso-Bumpus Debra | Chief People Office ... | Grant | A | 0.00 | 13,062 | 0 | 32,567 | 19.5 K to 32.6 K (+66.97 %) |
| Mar 03 2021 | BPMC | Blueprint Medicine ... | Murray Christopher K. | SVP, Technical Oper ... | Option Exercise | A | 100.13 | 12,500 | 1,251,625 | 12,500 | |
| Mar 03 2021 | BPMC | Blueprint Medicine ... | Murray Christopher K. | SVP, Technical Oper ... | Grant | A | 0.00 | 6,250 | 0 | 20,098 | 13.8 K to 20.1 K (+45.13 %) |
| Mar 03 2021 | BPMC | Blueprint Medicine ... | Hurley Ariel | Principal Accountin ... | Option Exercise | M | 8.80 | 300 | 2,640 | 2,664 | |
| Mar 03 2021 | BPMC | Blueprint Medicine ... | Hurley Ariel | Principal Accountin ... | Option Exercise | M | 1.87 | 1,400 | 2,618 | 5,754 | |
| Mar 03 2021 | BPMC | Blueprint Medicine ... | Hurley Ariel | Principal Accountin ... | Option Exercise | A | 100.13 | 6,375 | 638,329 | 6,375 | |
| Mar 03 2021 | BPMC | Blueprint Medicine ... | Hurley Ariel | Principal Accountin ... | Sell | S | 99.51 | 1,700 | 169,167 | 13,171 | 14.9 K to 13.2 K (-11.43 %) |
| Mar 03 2021 | BPMC | Blueprint Medicine ... | Hurley Ariel | Principal Accountin ... | Buy | M | 8.80 | 300 | 2,640 | 14,871 | 14.6 K to 14.9 K (+2.06 %) |
| Mar 03 2021 | BPMC | Blueprint Medicine ... | Hurley Ariel | Principal Accountin ... | Buy | M | 1.87 | 1,400 | 2,618 | 14,571 | 13.2 K to 14.6 K (+10.63 %) |
| Mar 03 2021 | BPMC | Blueprint Medicine ... | Hurley Ariel | Principal Accountin ... | Grant | A | 0.00 | 3,187 | 0 | 13,171 | 10 K to 13.2 K (+31.92 %) |
| Mar 03 2021 | BPMC | Blueprint Medicine ... | Hewes L. Becker | Chief Medical Offic ... | Option Exercise | A | 100.13 | 26,125 | 2,615,896 | 26,125 | |
| Mar 03 2021 | BPMC | Blueprint Medicine ... | Hewes L. Becker | Chief Medical Offic ... | Grant | A | 0.00 | 13,062 | 0 | 30,562 | 17.5 K to 30.6 K (+74.64 %) |
| Feb 24 2021 | BPMC | Blueprint Medicine ... | Dorsch Marion | Chief Scientific Of ... | Option Exercise | M | 37.11 | 7,578 | 281,220 | 40,422 | |
| Feb 24 2021 | BPMC | Blueprint Medicine ... | Dorsch Marion | Chief Scientific Of ... | Sell | S | 100.00 | 7,578 | 757,800 | 15,250 | 22.8 K to 15.3 K (-33.20 %) |
| Feb 24 2021 | BPMC | Blueprint Medicine ... | Dorsch Marion | Chief Scientific Of ... | Buy | M | 37.11 | 7,578 | 281,220 | 22,828 | 15.3 K to 22.8 K (+49.69 %) |
| Dec 28 2020 | BPMC | Blueprint Medicine ... | Goldberg Mark Alan | Director | Option Exercise | M | 28.15 | 5,455 | 153,558 | 0 | |
| Dec 28 2020 | BPMC | Blueprint Medicine ... | Goldberg Mark Alan | Director | Sell | S | 125.00 | 5,455 | 681,875 | 3,562 | 9 K to 3.6 K (-60.50 %) |
| Dec 28 2020 | BPMC | Blueprint Medicine ... | Goldberg Mark Alan | Director | Buy | M | 28.15 | 5,455 | 153,558 | 9,017 | 3.6 K to 9 K (+153.14 %) |
| Dec 22 2020 | BPMC | Blueprint Medicine ... | Goldberg Mark Alan | Director | Option Exercise | M | 28.15 | 5,454 | 153,530 | 5,455 | |
| Dec 22 2020 | BPMC | Blueprint Medicine ... | Goldberg Mark Alan | Director | Sell | S | 120.00 | 5,454 | 654,480 | 3,562 | 9 K to 3.6 K (-60.49 %) |
| Dec 22 2020 | BPMC | Blueprint Medicine ... | Goldberg Mark Alan | Director | Buy | M | 28.15 | 5,454 | 153,530 | 9,016 | 3.6 K to 9 K (+153.12 %) |
| Dec 18 2020 | BPMC | Blueprint Medicine ... | Rowland Charles A Jr | Director | Option Exercise | M | 19.53 | 10,909 | 213,053 | 0 | |
| Dec 18 2020 | BPMC | Blueprint Medicine ... | Rowland Charles A Jr | Director | Sell | S | 117.82 | 10,909 | 1,285,298 | 3,562 | 14.5 K to 3.6 K (-75.39 %) |
| Dec 18 2020 | BPMC | Blueprint Medicine ... | Rowland Charles A Jr | Director | Buy | M | 19.53 | 10,909 | 213,053 | 14,471 | 3.6 K to 14.5 K (+306.26 %) |
| Dec 16 2020 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Option Exercise | M | 8.80 | 5,000 | 44,000 | 17,170 | |
| Dec 16 2020 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 119.18 | 5,000 | 595,900 | 141,434 | 146.4 K to 141.4 K (-3.41 %) |
| Dec 16 2020 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Buy | M | 8.80 | 5,000 | 44,000 | 146,434 | 141.4 K to 146.4 K (+3.54 %) |
| Dec 16 2020 | BPMC | Blueprint Medicine ... | Boral Anthony L. | Chief Medical Offic ... | Option Exercise | M | 15.01 | 10,000 | 150,100 | 7,483 | |
| Dec 16 2020 | BPMC | Blueprint Medicine ... | Boral Anthony L. | Chief Medical Offic ... | Sell | S | 116.75 | 215 | 25,101 | 28,147 | 28.4 K to 28.1 K (-0.76 %) |
| Dec 16 2020 | BPMC | Blueprint Medicine ... | Boral Anthony L. | Chief Medical Offic ... | Sell | S | 117.92 | 1,970 | 232,302 | 28,362 | 30.3 K to 28.4 K (-6.49 %) |
| Dec 16 2020 | BPMC | Blueprint Medicine ... | Boral Anthony L. | Chief Medical Offic ... | Sell | S | 118.72 | 7,815 | 927,797 | 30,332 | 38.1 K to 30.3 K (-20.49 %) |
| Dec 16 2020 | BPMC | Blueprint Medicine ... | Boral Anthony L. | Chief Medical Offic ... | Buy | M | 15.01 | 10,000 | 150,100 | 38,147 | 28.1 K to 38.1 K (+35.53 %) |
| Dec 16 2020 | BPMC | Blueprint Medicine ... | Dorsch Marion | Chief Scientific Of ... | Option Exercise | M | 37.11 | 4,600 | 170,706 | 48,000 | |
| Dec 16 2020 | BPMC | Blueprint Medicine ... | Dorsch Marion | Chief Scientific Of ... | Sell | S | 119.00 | 4,600 | 547,400 | 15,250 | 19.9 K to 15.3 K (-23.17 %) |
| Dec 16 2020 | BPMC | Blueprint Medicine ... | Dorsch Marion | Chief Scientific Of ... | Buy | M | 37.11 | 4,600 | 170,706 | 19,850 | 15.3 K to 19.9 K (+30.16 %) |
| Dec 15 2020 | BPMC | Blueprint Medicine ... | Goldberg Mark Alan | Director | Option Exercise | M | 28.15 | 5,455 | 153,558 | 10,909 | |
| Dec 15 2020 | BPMC | Blueprint Medicine ... | Goldberg Mark Alan | Director | Sell | S | 115.00 | 5,455 | 627,325 | 3,562 | 9 K to 3.6 K (-60.50 %) |
| Dec 15 2020 | BPMC | Blueprint Medicine ... | Goldberg Mark Alan | Director | Buy | M | 28.15 | 5,455 | 153,558 | 9,017 | 3.6 K to 9 K (+153.14 %) |
| Dec 03 2020 | BPMC | Blueprint Medicine ... | Goldberg Mark Alan | Director | Option Exercise | M | 28.15 | 5,454 | 153,530 | 16,364 | |
| Dec 03 2020 | BPMC | Blueprint Medicine ... | Goldberg Mark Alan | Director | Sell | S | 110.00 | 5,454 | 599,940 | 3,562 | 9 K to 3.6 K (-60.49 %) |
| Dec 03 2020 | BPMC | Blueprint Medicine ... | Goldberg Mark Alan | Director | Buy | M | 28.15 | 5,454 | 153,530 | 9,016 | 3.6 K to 9 K (+153.12 %) |
| Dec 03 2020 | BPMC | Blueprint Medicine ... | Hurley Ariel | Principal Accountin ... | Option Exercise | M | 8.80 | 900 | 7,920 | 2,964 | |
| Dec 03 2020 | BPMC | Blueprint Medicine ... | Hurley Ariel | Principal Accountin ... | Sell | S | 110.00 | 900 | 99,000 | 9,984 | 10.9 K to 10 K (-8.27 %) |
| Dec 03 2020 | BPMC | Blueprint Medicine ... | Hurley Ariel | Principal Accountin ... | Buy | M | 8.80 | 900 | 7,920 | 10,884 | 10 K to 10.9 K (+9.01 %) |
| Dec 03 2020 | BPMC | Blueprint Medicine ... | Hurley Ariel | Principal Accountin ... | Sell | S | 109.08 | 138 | 15,053 | 9,984 | 10.1 K to 10 K (-1.36 %) |
| Nov 18 2020 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Option Exercise | M | 36.05 | 409 | 14,744 | 4,591 | |
| Nov 18 2020 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Sell | S | 100.27 | 409 | 41,010 | 42,838 | 43.2 K to 42.8 K (-0.95 %) |
| Nov 18 2020 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Buy | M | 36.05 | 409 | 14,744 | 43,247 | 42.8 K to 43.2 K (+0.95 %) |
| Nov 18 2020 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Option Exercise | M | 8.80 | 20,000 | 176,000 | 22,170 | |
| Nov 18 2020 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 97.61 | 6,521 | 636,515 | 141,434 | 148 K to 141.4 K (-4.41 %) |
| Nov 18 2020 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 98.13 | 4,483 | 439,917 | 147,955 | 152.4 K to 148 K (-2.94 %) |
| Nov 18 2020 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 99.55 | 4,869 | 484,709 | 152,438 | 157.3 K to 152.4 K (-3.10 %) |
| Nov 18 2020 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 100.11 | 4,127 | 413,154 | 157,307 | 161.4 K to 157.3 K (-2.56 %) |
| Nov 18 2020 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Buy | M | 8.80 | 20,000 | 176,000 | 161,434 | 141.4 K to 161.4 K (+14.14 %) |
| Nov 18 2020 | BPMC | Blueprint Medicine ... | Hurley Ariel | Principal Accountin ... | Option Exercise | M | 1.87 | 1,400 | 2,618 | 7,154 | |
| Nov 18 2020 | BPMC | Blueprint Medicine ... | Hurley Ariel | Principal Accountin ... | Option Exercise | M | 8.80 | 300 | 2,640 | 3,864 | |
| Nov 18 2020 | BPMC | Blueprint Medicine ... | Hurley Ariel | Principal Accountin ... | Sell | S | 100.92 | 1,700 | 171,564 | 9,984 | 11.7 K to 10 K (-14.55 %) |
| Nov 18 2020 | BPMC | Blueprint Medicine ... | Hurley Ariel | Principal Accountin ... | Buy | M | 1.87 | 1,400 | 2,618 | 11,684 | 10.3 K to 11.7 K (+13.61 %) |
| Nov 18 2020 | BPMC | Blueprint Medicine ... | Hurley Ariel | Principal Accountin ... | Buy | M | 8.80 | 300 | 2,640 | 10,284 | 10 K to 10.3 K (+3.00 %) |
| Nov 05 2020 | BPMC | Blueprint Medicine ... | Rossi Christina | Chief Commercial Of ... | Sell | S | 99.69 | 345 | 34,393 | 20,020 | 20.4 K to 20 K (-1.69 %) |
| Nov 04 2020 | BPMC | Blueprint Medicine ... | Rowland Charles A Jr | Director | Option Exercise | M | 9.46 | 5,522 | 52,238 | 0 | |
| Nov 04 2020 | BPMC | Blueprint Medicine ... | Rowland Charles A Jr | Director | Option Exercise | M | 9.46 | 4,478 | 42,362 | 5,522 | |
| Nov 04 2020 | BPMC | Blueprint Medicine ... | Rowland Charles A Jr | Director | Sell | S | 95.97 | 694 | 66,603 | 3,562 | 4.3 K to 3.6 K (-16.31 %) |
| Nov 04 2020 | BPMC | Blueprint Medicine ... | Rowland Charles A Jr | Director | Sell | S | 99.10 | 4,728 | 468,545 | 4,256 | 9 K to 4.3 K (-52.63 %) |
| Nov 04 2020 | BPMC | Blueprint Medicine ... | Rowland Charles A Jr | Director | Sell | S | 100.48 | 100 | 10,048 | 8,984 | 9.1 K to 9 K (-1.10 %) |
| Nov 04 2020 | BPMC | Blueprint Medicine ... | Rowland Charles A Jr | Director | Buy | M | 9.46 | 5,522 | 52,238 | 9,084 | 3.6 K to 9.1 K (+155.03 %) |
| Nov 04 2020 | BPMC | Blueprint Medicine ... | Rowland Charles A Jr | Director | Sell | S | 99.11 | 4,478 | 443,815 | 3,562 | 8 K to 3.6 K (-55.70 %) |
| Nov 04 2020 | BPMC | Blueprint Medicine ... | Rowland Charles A Jr | Director | Buy | M | 9.46 | 4,478 | 42,362 | 8,040 | 3.6 K to 8 K (+125.72 %) |
| Oct 27 2020 | BPMC | Blueprint Medicine ... | Boral Anthony L. | Chief Medical Offic ... | Option Exercise | M | 8.80 | 3,409 | 29,999 | 0 | |
| Oct 27 2020 | BPMC | Blueprint Medicine ... | Boral Anthony L. | Chief Medical Offic ... | Option Exercise | M | 15.01 | 5,774 | 86,668 | 0 | |
| Oct 27 2020 | BPMC | Blueprint Medicine ... | Boral Anthony L. | Chief Medical Offic ... | Buy | M | 8.80 | 3,409 | 29,999 | 28,147 | 24.7 K to 28.1 K (+13.78 %) |
| Oct 27 2020 | BPMC | Blueprint Medicine ... | Boral Anthony L. | Chief Medical Offic ... | Buy | M | 15.01 | 5,774 | 86,668 | 24,738 | 19 K to 24.7 K (+30.45 %) |
| Oct 21 2020 | BPMC | Blueprint Medicine ... | Goldberg Mark Alan | Director | Option Exercise | M | 19.53 | 5,455 | 106,536 | 0 | |
| Oct 21 2020 | BPMC | Blueprint Medicine ... | Goldberg Mark Alan | Director | Sell | S | 105.00 | 5,455 | 572,775 | 3,562 | 9 K to 3.6 K (-60.50 %) |
| Oct 21 2020 | BPMC | Blueprint Medicine ... | Goldberg Mark Alan | Director | Buy | M | 19.53 | 5,455 | 106,536 | 9,017 | 3.6 K to 9 K (+153.14 %) |
| Oct 20 2020 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Option Exercise | M | 36.05 | 13,334 | 480,691 | 5,000 | |
| Oct 20 2020 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Sell | S | 100.55 | 7,200 | 723,960 | 42,838 | 50 K to 42.8 K (-14.39 %) |
| Oct 20 2020 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Sell | S | 101.56 | 3,125 | 317,375 | 50,038 | 53.2 K to 50 K (-5.88 %) |
| Oct 20 2020 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Sell | S | 102.53 | 3,009 | 308,513 | 53,163 | 56.2 K to 53.2 K (-5.36 %) |
| Oct 20 2020 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Buy | M | 36.05 | 13,334 | 480,691 | 56,172 | 42.8 K to 56.2 K (+31.13 %) |
| Oct 09 2020 | BPMC | Blueprint Medicine ... | Hurley Ariel | Principal Accountin ... | Option Exercise | M | 8.80 | 600 | 5,280 | 4,164 | |
| Oct 09 2020 | BPMC | Blueprint Medicine ... | Hurley Ariel | Principal Accountin ... | Sell | S | 100.00 | 600 | 60,000 | 9,984 | 10.6 K to 10 K (-5.67 %) |
| Oct 09 2020 | BPMC | Blueprint Medicine ... | Hurley Ariel | Principal Accountin ... | Buy | M | 8.80 | 600 | 5,280 | 10,584 | 10 K to 10.6 K (+6.01 %) |
| Oct 09 2020 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Option Exercise | M | 8.80 | 5,000 | 44,000 | 42,170 | |
| Oct 09 2020 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 99.17 | 5,000 | 495,850 | 141,434 | 146.4 K to 141.4 K (-3.41 %) |
| Oct 09 2020 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Buy | M | 8.80 | 5,000 | 44,000 | 146,434 | 141.4 K to 146.4 K (+3.54 %) |
| Oct 08 2020 | BPMC | Blueprint Medicine ... | Dorsch Marion | Chief Scientific Of ... | Option Exercise | M | 37.11 | 4,600 | 170,706 | 52,600 | |
| Oct 08 2020 | BPMC | Blueprint Medicine ... | Dorsch Marion | Chief Scientific Of ... | Sell | S | 99.00 | 4,600 | 455,400 | 15,250 | 19.9 K to 15.3 K (-23.17 %) |
| Oct 08 2020 | BPMC | Blueprint Medicine ... | Dorsch Marion | Chief Scientific Of ... | Buy | M | 37.11 | 4,600 | 170,706 | 19,850 | 15.3 K to 19.9 K (+30.16 %) |
| Sep 25 2020 | BPMC | Blueprint Medicine ... | Dorsch Marion | Chief Scientific Of ... | Option Exercise | M | 37.11 | 4,600 | 170,706 | 57,200 | |
| Sep 25 2020 | BPMC | Blueprint Medicine ... | Dorsch Marion | Chief Scientific Of ... | Sell | S | 89.00 | 4,600 | 409,400 | 15,250 | 19.9 K to 15.3 K (-23.17 %) |
| Sep 25 2020 | BPMC | Blueprint Medicine ... | Dorsch Marion | Chief Scientific Of ... | Buy | M | 37.11 | 4,600 | 170,706 | 19,850 | 15.3 K to 19.9 K (+30.16 %) |
| Sep 25 2020 | BPMC | Blueprint Medicine ... | Hurley Ariel | Principal Accountin ... | Option Exercise | M | 1.87 | 1,400 | 2,618 | 8,554 | |
| Sep 25 2020 | BPMC | Blueprint Medicine ... | Hurley Ariel | Principal Accountin ... | Sell | S | 90.00 | 1,400 | 126,000 | 9,984 | 11.4 K to 10 K (-12.30 %) |
| Sep 25 2020 | BPMC | Blueprint Medicine ... | Hurley Ariel | Principal Accountin ... | Buy | M | 1.87 | 1,400 | 2,618 | 11,384 | 10 K to 11.4 K (+14.02 %) |
| Sep 25 2020 | BPMC | Blueprint Medicine ... | Durso-Bumpus Debra | Chief People Office ... | Option Exercise | M | 36.05 | 1,900 | 68,495 | 28,300 | |
| Sep 25 2020 | BPMC | Blueprint Medicine ... | Durso-Bumpus Debra | Chief People Office ... | Sell | S | 90.02 | 1,900 | 171,038 | 19,505 | 21.4 K to 19.5 K (-8.88 %) |
| Sep 25 2020 | BPMC | Blueprint Medicine ... | Durso-Bumpus Debra | Chief People Office ... | Buy | M | 36.05 | 1,900 | 68,495 | 21,405 | 19.5 K to 21.4 K (+9.74 %) |
| Sep 24 2020 | BPMC | Blueprint Medicine ... | Demetri George | Director | Sell | S | 85.00 | 1,704 | 144,840 | 4,320 | 6 K to 4.3 K (-28.29 %) |
| Sep 24 2020 | BPMC | Blueprint Medicine ... | Boral Anthony L. | Chief Medical Offic ... | Option Exercise | M | 15.01 | 6,864 | 103,029 | 17,483 | |
| Sep 24 2020 | BPMC | Blueprint Medicine ... | Boral Anthony L. | Chief Medical Offic ... | Sell | S | 82.33 | 6,864 | 565,113 | 18,964 | 25.8 K to 19 K (-26.58 %) |